The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: A multi-centre registry study

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Cho, Yeoungjee ^a,b   Badve, Sunil V ^a,b   Hawley, Carmel M ^a,b   McDonald, Stephen P ^a,c   Brown, Fiona G ^a,d   M, Neil Boudville ^a,e   Wiggins, Kathryn J ^a,f   Bannister, Kym M ^a,g   Clayton, Philip ^a,h   Johnson, David W ^a,b,i  

^a Australia and New Zealand Dialysis and Transplant Registry   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d Monash Medical Center   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f ROYAL MELBOURNE HOSPITAL   (Australia)

^g ROYAL ADELAIDE HOSPITAL   (Australia)

^h ROYAL PRINCE ALFRED HOSPITAL   (Australia)

ⁱ PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Antibiotics; Bacteria; Fungus; Microbiology; Outcomes; Peritoneal Dialysis; Peritonitis; Relapse; Remoteness

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEFAZOLIN; CEPHALOSPORIN DERIVATIVE; FIBRINOLYTIC AGENT; GENTAMICIN; HEPARIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CORYNEBACTERIUM; DEMOGRAPHY; DISEASE FREE SURVIVAL; ENTEROCOCCUS; FEMALE; HEMODIALYSIS; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM; PERITONEAL DIALYSIS; PERITONITIS; PSEUDOMONAS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; AUSTRALIA; DRUG THERAPY, COMBINATION; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; REGISTRIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 84862234669     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-41     Document Type: Article

References (26)

1. Peritoneal Dialysis. Johnson DW, Chang S, Excell L, Livingston B, Bannister K, McDonald SP, ANZDATA Registry Report 2006 Australian and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia, McDonald SP, Excell L, 2007 87 103
2. Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Johnson DW, Dent H, Hawley CM, McDonald SP, Rosman JB, Brown F, Bannister K, Wiggins KJ, Am J Kidney Dis 2009 53 290 297 10.1053/j.ajkd.2008.06.032 18805609
3. Polymicrobial Peritonitis in Peritoneal Dialysis Patients in Australia: Predictors, Treatment, and Outcomes. Barraclough K, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister K, Johnson DW, Am J Kidney Dis 2010 55 121 131 10.1053/j.ajkd.2009.08.020 19932543
4. Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases. Barraclough K, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW, Nephrol Dial Transplant 2009 24 3834 3839 10.1093/ndt/gfp322 19574339
5. Enterococcal peritonitis in Australian Peritoneal Dialysis Patients: Predictors, Treatment and Outcomes in 116 cases. Edey M, Hawley C, McDonald SP, Brown F, Rosman JB, Wiggins KJ, Bannister K, Johnson DW, Nephrol Dial Transplant 2009 25 1272 1278 19948875
6. Culture-Negative Peritonitis in Peritoneal Dialysis Patients in Australia: Predictors, Treatment and Outcomes in 435 cases. Fahim M, Hawley CM, McDonald SP, Brown F, Rosman JB, Wiggins KJ, Bannister K, Johnson DW, Am J Kidney Dis 2009 55 690 697
7. Coagulase negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases. Fahim M, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW, Nephrol Dial Transplant 2010 25 3386 3392 10.1093/ndt/gfq222 20466663
8. Staphylococcus aureus Peritonitis in Australian Peritoneal Dialysis Patients: Predictors, Treatment and Outcomes in 503 cases. Govindarajulu S, Hawley C, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister K, Johnson DW, Perit Dial Int 2009 30 311 319
9. Non-pseudomonas gram negative peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 837 cases. Jarvis E, Hawley C, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW, Kidney Int 2010 78 408 414 10.1038/ki.2010.149 20505659
10. Peritoneal dialysis practice in Australia and New Zealand: A call to action. Jose M, Johnson DW, Mudge DW, Tranaeus A, Voss D, Walker R, Bannister KM, Nephrology 2011 16 19 29 10.1111/j.1440-1797.2010.01390.x 21175973
11. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Miles R, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister K, Johnson DW, Kidney Int 2009 76 622 628 10.1038/ki.2009.202 19516241
12. Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases. O'Shea S, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW, BMC Nephrol 2009 10 19 10.1186/1471-2369-10-19 19631002
13. Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Siva B, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW, Clin J Am Soc Nephrol 2009 4 957 964 10.2215/CJN.00010109 19406972
14. Remote indigenous peritoneal dialysis patients have higher risk of peritonitis, technique failure, all-cause and peritonitis-related mortality. Lim WH, Boudville N, McDonald SP, Gorham G, Johnson DW, Jose M, Nephrol Dial Transplant 2011 26 3366 3372 10.1093/ndt/gfr070 21382988
15. Mortality of Canadians treated by peritoneal dialysis in remote locations. Tonelli M, Hemmelgarn B, Culleton B, Klarenbach S, Gill JS, Wiebe N, Manns B, Kidney Int 2007 72 1023 1028 10.1038/sj.ki.5002443 17637709
16. Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA. Lim WH, Johnson DW, McDonald SP, Nephrology (Carlton) 2005 10 192 197 10.1111/j.1440-1797.2005.00374.x
17. Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis. Pignatari A, Pfaller M, Hollis R, Sesso R, Leme I, Herwaldt L, J Clin Microbiol 1990 28 1898 1902 2172293
18. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Xu G, Tu W, Xu C, Nephrol Dial Transplant 2010 25 587 592 10.1093/ndt/gfp411 19679557
19. Adherence to guideline recommendations for infection prophylaxis in peritoneal dialysis patients. Badve SV, Hawley CM, Johnson DW, Nephrol Dial Transplant Plus 2009 2 508
20. Peritoneal dialysis practice in Australia and New Zealand: A call to action. Jose M, Johnson DW, Mudge DW, Tranaeus A, Voss D, Walker R, Bannister KM, Nephrology 2011 16 19 29 10.1111/j.1440-1797.2010.01390.x 21175973
21. Adverse outcomes among Aboriginal patients receiving peritoneal dialysis. Sood MM, Komenda P, Sood AR, Reslerova M, Verrelli M, Sathianathan C, Eng L, Eng A, Rigatto C, CMAJ 2010 182 1433 1439 10.1503/cmaj.100105 20660579
22. Geographic and Educational Factors and Risk of the First Peritonitis Episode in Brazilian Peritoneal Dialysis Study (BRAZPD) Patients. Martin LC, Caramori JC, Fernandes N, Divino-Filho JC, Pecoits-Filho R, Barretti P, Clin J Am Soc Nephrol 2011 6 1944 1951 10.2215/CJN.11431210 21737854
23. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003. Davenport A, Perit Dial Int 2009 29 297 302 19458302
24. Peritoneal dialysis-associated peritonitis in Scotland (1999-2002). Kavanagh D, Prescott GJ, Mactier RA, Nephrol Dial Transplant 2004 19 2584 2591 10.1093/ndt/gfh386 15304559
25. Peritoneal dialysis-related infections recommendations: 2010 update. Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, Johnson DW, Kuijper EJ, Lye WC, Salzer W, Perit Dial Int 2010 30 393 423 10.3747/pdi.2010.00049 20628102
26. ISPD-position statement on reducing the risks of peritoneal dialysis-related infections. Piraino B, Bernardini J, Brown E, Figueiredo A, Johnson DW, Lye WC, Price V, Ramalakshmi S, Szeto CC, Perit Dial Int 2011 31 614 630 10.3747/pdi.2011.00057 21880990